CytoMed Therapeutics Limited (GDTC)

NASDAQ: GDTC · Real-Time Price · USD

1.050

-0.010 (-0.94%)

Mar 16, 2026, 4:00 PM EDT - Market closed

CytoMed Therapeutics Employees

CytoMed Therapeutics had 43 employees as of December 31, 2024. The number of employees increased by 9 or 26.47% compared to the previous year.

Employees

43

Change (1Y)

9

Growth (1Y)

26.47%

Revenue / Employee

$13,330

Profits / Employee

-$67,065

Market Cap

12.12M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	43	9	26.47%
Dec 31, 2023	34	-	-

Related Stocks

Company Name	Employees
IO Biotech	78
BioAtla	61
Curis	34
BioLineRx	28
Soligenix	16
NewcelX	15
BioVie	13
Purple Biotech	9

Employee Rankings

GDTC News

5 months ago - CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
5 months ago - CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia - GlobeNewsWire
7 months ago - Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition - GlobeNewsWire
7 months ago - CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program - GlobeNewsWire
8 months ago - Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies - GlobeNewsWire
11 months ago - CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates - GlobeNewsWire
1 year ago - CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders - GlobeNewsWire
1 year ago - Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor - Benzinga